CHRISTINA CURRAN: Open Payments
NPI 1952333577 · TAMARAC, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,106 in 42 payments from 14 companies in 2025. Trend: 2023 $587 · 2024 $930 · 2025 $1,106
Food & beverage: $954Education: $152
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $224 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $195 |
| Regeneron Healthcare Solutions, Inc. | 4 | $120 |
| ABBVIE INC. | 4 | $95 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 3 | $68 |
| UCB, Inc. | 3 | $67 |
| GENZYME CORPORATION | 2 | $64 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Lilly USA, LLC | 2 | $45 |
Products named: TREMFYA, DUPIXENT, SPEVIGO, ILUMYA, Bimzelx, RINVOQ, SKYRIZI, EBGLYSS.
Industry payments across FL — which companies pay providers there.
